株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

好酸球性食道炎:世界の治験レビュー

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 240613
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.16円で換算しております。
Back to Top
好酸球性食道炎:世界の治験レビュー Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016
出版日: 2016年11月30日 ページ情報: 英文 68 Pages
概要

当レポートでは、好酸球性食道炎に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7ーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 好酸球性食道炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米

G7諸国における治験件数:好酸球性食道炎治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数:G7諸国

G7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 好酸球性食道炎治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • Sanofi
    • Regeneron Pharmaceuticals, Inc.
    • Shire Plc
    • Teva Pharmaceutical Industries Limited
    • GlaxoSmithKline plc
    • Oxagen Limited
    • Novartis AG
    • Medpace, Inc.
    • AstraZeneca PLC
    • Actavis plc
  • 代表的な研究機関/病院の治験の概要
    • Mayo Clinic
    • Cincinnati Children's Hospital Medical Center
    • Academic Medical Center
    • Swiss EE Study Group
    • Azienda Universitaria Policlinico Umberto I di Roma
    • Baylor College of Medicine
    • Children's Hospital Medical Center of Akron
    • Dallas VA Medical Center
    • Medical College of Wisconsin
    • Murdoch Childrens Research Institute

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3922CTIDB

GlobalData's clinical trial report, "Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilic Esophagitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Clinical Trials by G7 Countries: Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials 11
  • Clinical Trials by Phase in G7 Countries 12
  • Clinical Trials in G7 Countries by Trial Status 13
  • Clinical Trials by Phase 14
  • In Progress Trials by Phase 15
  • Clinical Trials by Trial Status 16
  • Clinical Trials by End Point Status 17
  • Subjects Recruited Over a Period of Time 18
  • Clinical Trials by Sponsor Type 19
  • Prominent Sponsors 20
  • Top Companies Participating in Eosinophilic Esophagitis Therapeutics Clinical Trials 21
  • Prominent Drugs 23
  • Latest Clinical Trials News on Eosinophilic Esophagitis 24
  • Oct 13, 2016: Celgene to Present New Data on RPC4046 at UEGW and ACG Congresses 24
  • Clinical Trial Profile Snapshots 25

Appendix 65

  • Abbreviations 65
  • Definitions 65
  • Research Methodology 66
  • Secondary Research 66
  • About GlobalData 67
  • Contact Us 67
  • Disclaimer 67
  • Source 68

List of Tables

List of Tables

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 11
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase, 2016* 14
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 15
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 19
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23

List of Figures

List of Figures

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 11
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 14
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 15
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 19
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23
  • GlobalData Methodology 66
Back to Top